Zhejiang Doer Biologics Co., Ltd.
Clinical trials sponsored by Zhejiang Doer Biologics Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug combo aims to shrink hard-to-treat gut tumors Results expected Apr 2027 (estimated)
- New hope for advanced cancer: experimental drug DR30206 enters human testing Results expected Jul 2027 (estimated)